CME Group
Stock Forecast, Prediction & Price Target
CME Group (CME) stock Price Target by analysts
$243.5
Potential downside: -10.34%
CME Group price prediction
What is CME Group stock analysts` prediction?
CME Group stock forecast: Based on 4 Wall Street analysts` predicted price targets for CME Group in the last 3 months, the avarage price target is $243.5, with a high forecast of $NaN. The average price target represents a -10.34% change from the last price of $271.61.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
CME Group stock Price Target by analysts
Full breakdown of analysts given CME Group price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Owen Lau Oppenheimer | 0% 0/1 | 11 months ago | $258 -5.01% downside | $227.43 | StreetInsider | Previous targets (0) |
Benjamin Budish Barclays | 0% 0/3 | 11 months ago | $231 -14.95% downside | $227.14 | TheFly | Previous targets (2) |
Christopher Allen Citigroup | 0% 0/1 | 11 months ago | $250 -7.95% downside | $223.57 | TheFly | Previous targets (0) |
Ashish Sabadra RBC Capital | 0% 0/1 | 11 months ago | $235 -13.47% downside | $218.47 | TheFly | Previous targets (0) |
Craig Siegenthaler Bank of America Securities | 0% 0/1 | about 1 year ago | $177 -34.83% downside | $215.74 | TheFly | Previous targets (0) |
Patrick Moley Piper Sandler | 0% 0/1 | about 1 year ago | $225 -17.16% downside | $199.38 | StreetInsider | Previous targets (0) |
Brian Bedell Deutsche Bank | 0% 0/2 | about 1 year ago | $193 -28.94% downside | $198.92 | TheFly | Previous targets (1) |
Benjamin Budish Barclays | 0% 0/3 | about 1 year ago | $209 -23.05% downside | $197.25 | TheFly | Previous targets (2) |
Alex Kromm UBS | 0% 0/2 | over 1 year ago | $250 -7.95% downside | $203.78 | StreetInsider | Previous targets (1) |
Andrew Bond Rosenblatt Securities | 100% 1/1 | over 1 year ago | $187 -31.15% downside | $212.59 | StreetInsider | Previous targets (0) |
Benjamin Budish Barclays | 0% 0/3 | over 1 year ago | $228 -16.05% downside | $212.59 | TheFly | Previous targets (2) |
Brian Bedell Deutsche Bank | 0% 0/2 | over 1 year ago | $210 -22.68% downside | $212.21 | StreetInsider | Previous targets (1) |
Unknown Credit Suisse | N/A | over 2 years ago | $198 -27.10% downside | $174.76 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 2 years ago | $196 -27.83% downside | $176.93 | Benzinga | N/A |
Unknown Piper Sandler | N/A | over 2 years ago | $250 -7.95% downside | $171.12 | Benzinga | N/A |
Unknown Credit Suisse | N/A | almost 3 years ago | $210 -22.68% downside | $194.69 | Benzinga | N/A |
Unknown Rosenblatt Securities | N/A | about 3 years ago | $171 -37.04% downside | $205.46 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $212 -21.94% downside | $202.15 | Benzinga | N/A |
Unknown Credit Suisse | N/A | about 3 years ago | $216 -20.47% downside | $198.25 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $240 -11.63% downside | $195.34 | Benzinga | N/A |
Unknown Credit Suisse | N/A | about 3 years ago | $218 -19.73% downside | $195.99 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $226 -16.79% downside | $198.5 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $242 -10.90% downside | $201.51 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $213 -21.57% downside | $203.55 | Benzinga | N/A |
Unknown Credit Suisse | N/A | about 3 years ago | $233 -14.21% downside | $204.36 | Benzinga | N/A |
Unknown Raymond James | N/A | about 3 years ago | $235 -13.47% downside | $204.36 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $246 -9.42% downside | $204.36 | Benzinga | N/A |
Simon Clinch Atlantic Equities | 0% 0/1 | about 3 years ago | $235 -13.47% downside | $200.43 | Investing | Previous targets (0) |
Stephen Biggar Argus Research | 0% 0/1 | over 3 years ago | $230 -15.31% downside | $200.1 | StreetInsider | Previous targets (0) |
Alex Kromm UBS | 0% 0/2 | over 3 years ago | $269 -0.96% downside | $237.46 | Pulse 2.0 | Previous targets (1) |
Daniel Fannon Jefferies | 0% 0/1 | over 3 years ago | $258 -5.01% downside | $221.8 | StreetInsider | Previous targets (0) |
Eoin Mullany Berenberg Bank | 100% 1/1 | almost 4 years ago | $190 -30.04% downside | $215.65 | Investing | Previous targets (0) |
Richard Repetto Piper Sandler | 100% 1/1 | almost 4 years ago | $230 -15.31% downside | $192.18 | TheFly | Previous targets (0) |
Kenneth Hill Loop Capital Markets | 100% 1/1 | over 4 years ago | $151 -44.40% downside | $197.42 | StreetInsider | Previous targets (0) |
Alexander Blostein Goldman Sachs | 100% 1/1 | over 4 years ago | $208 -23.41% downside | $194.79 | StreetInsider | Previous targets (0) |
CME Group Financial Estimates
CME Group Revenue Estimates
CME Group EBITDA Estimates
CME Group Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.68B N/A | $5.01B 7.03% | $5.57B 11.14% | Avg: $6.11B Low: $5.95B High: $6.29B avg. 9.59% | Avg: $6.46B Low: $6.21B High: $6.67B avg. 5.73% | Avg: $7.01B Low: $6.75B High: $7.25B avg. 8.57% | Avg: $7.06B Low: $6.79B High: $7.29B avg. 0.66% |
Net Income
% change YoY
| $2.63B N/A | $2.69B 2.07% | $3.22B 19.88% | Avg: $3.45B Low: $3.19B High: $3.66B avg. 7.09% | Avg: $3.65B Low: $3.27B High: $3.91B avg. 5.81% | Avg: $4.10B Low: $3.89B High: $4.27B avg. 12.17% | Avg: $4.08B Low: $3.87B High: $4.25B avg. -0.49% |
EBITDA
% change YoY
| $2.79B N/A | $3.15B 12.81% | $3.78B 20.23% | Avg: $3.71B Low: $3.61B High: $3.82B avg. -1.93% | Avg: $3.92B Low: $3.77B High: $4.05B avg. 5.73% | Avg: $4.26B Low: $4.10B High: $4.40B avg. 8.57% | Avg: $4.29B Low: $4.12B High: $4.43B avg. 0.66% |
EPS
% change YoY
| $7.3 N/A | $7.41 1.50% | $8.87 19.70% | Avg: $9.55 Low: $8.89 High: $10.2 avg. 7.68% | Avg: $10.09 Low: $9.12 High: $10.89 avg. 5.66% | Avg: $11.41 Low: $10.84 High: $11.9 avg. 13.01% | Avg: $11.35 Low: $10.79 High: $11.84 avg. -0.49% |
Operating Expenses
% change YoY
| $1.20B N/A | $1.25B 3.55% | $1.10B -11.65% | Avg: $196.31M Low: $191.14M High: $202.12M avg. -82.22% | Avg: $207.56M Low: $199.66M High: $214.42M avg. 5.73% | Avg: $225.36M Low: $216.77M High: $232.81M avg. 8.57% | Avg: $226.87M Low: $218.23M High: $234.37M avg. 0.66% |
FAQ
What is CME Group stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 6.14% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is 3.19B, average is 3.45B and high is 3.66B.
What is CME Group stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6.14% in 2025-2028.
We have gathered data from 12 analysts. Their low revenue estimate is $5.95B, average is $6.11B and high is $6.29B.
What is CME Group stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 6.46% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is $8.89, average is $9.55 and high is $10.19.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering CME Group stock. The most successful analyst is Owen Lau.